The Real Estate sales sector has shown signs of temporary stabilization, and related sectors are expected to experience positive changes.
① According to media reports, it has been learned that several first-tier cities are studying and preparing policies related to stabilizing the real estate market. ② Kaiyuan Securities predicts that policy adjustments in first-tier cities will provide strong support on the demand side and gradually improve expectations for housing prices, which will in turn radiate to second- and third-tier cities, gradually achieving stabilization in housing prices and improving the fundamentals of the real estate market.
Brokerage morning meeting highlights: The USA has increased tariffs on China, but the impact on these industries in the A-shares may be limited.
In today's brokerage morning meeting, GF SEC believes that the USA's tariffs on China have a limited impact on the A-share Computer Industry; China Securities Co.,Ltd. suggested being Bullish on the Innovative Drugs industry that is currently not affected by tariffs; Galaxy Securities stated that Deep Sea Technology has entered a new stage in Global Strategy, focusing on opportunities in core equipment.
China Securities Co.,Ltd. Earnings Conference "Direct Hit": How to apply large models? How to respond to the reduction in investment banking volume? How to innovate in the wealth business?
Achieve top-tier status domestically within 5 years and attain international competitiveness within 10 years.
Investment income increased by 65%! China Securities Co., Ltd. annual report is officially released!
Wealth management is thriving uniquely.
In Q4, China Securities Co., Ltd. revenue increased by 40.2% year-on-year, with Net income soaring by 117.8% year-on-year, and Asset Management scale rising to 494.86 billion yuan | Earnings Reports insights.
Affected by the market environment, the investment Banks business revenue for the year was 2.491 billion yuan, a significant decrease of 48.14% year-on-year. The wealth management Business performed exceptionally well, achieving revenue of 6.61 billion yuan for the year, an increase of 8.97% compared to the previous year. The company plans to distribute a cash dividend of 1.65 yuan (tax included) for every 10 shares to all Shareholders.
Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.